Occuity receives a grant of PS343k to develop an optical diabetes screening device
DISCLOSURE: Longevity. The company in this article has contracted with First Longevity Limited’s Technology (a brand) to support their current funding round. Investors who qualify can learn more at Longevity. Portal for technology investment.
MedTech startup Occuity received a PS343,000 award from Innovate UK Biomedical Catalyst Award (BMC). This will fund the next phase of development of their innovative AGE Reader: an optical medical tool that allows non-invasive diabetes screening in non-clinical environments such as pharmacies and opticians.
Biomedical Catalyst, the Innovate UK flagship grant competition for UK health and life sciences SMEs, is funded by Innovate UK. It provides financial support for the development of innovative healthcare and health solutions.
Source:
Occuity lands £343k grant to develop optical diabetes screening device
